Oppenheimer downgraded JPMorgan Chase from Outperform to Perform
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/27/2025 | $235.00 | Neutral → Underperform | Robert W. Baird |
| 5/15/2025 | $305.00 | Buy | TD Cowen |
| 3/7/2025 | $215.00 → $220.00 | Underperform → Neutral | Robert W. Baird |
| 1/3/2025 | $269.00 | Peer Perform → Outperform | Wolfe Research |
| 11/20/2024 | Outperform → Perform | Oppenheimer | |
| 11/7/2024 | $200.00 | Neutral → Underperform | Robert W. Baird |
| 9/30/2024 | $220.00 → $224.00 | Overweight → Equal-Weight | Morgan Stanley |
| 9/3/2024 | $235.00 | Buy → Hold | Deutsche Bank |
4 - JPMORGAN CHASE & CO (0000019617) (Reporting)
JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") announced today that it has released the results of its company-run 2025 Dodd-Frank Act Stress Test for JPMorganChase and JPMorgan Chase Bank, National Association. Information can be found on the Firm's website at www.jpmorganchase.com under Investor Relations, Events & Presentations. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorganChase had $4.4 trillion in assets and $351 billion in stockholders' equity as of March 31, 2025. The Firm is a leader in investment banking, financial services for consumers and small businesses
JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") has announced updated information relating to its third quarter dividend, common share repurchase program and regulatory capital requirements. Information can be found on the Firm's Investor Relations website at jpmorganchase.com/ir/news. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorganChase had $4.4 trillion in assets and $351 billion in stockholders' equity as of March 31, 2025. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction proc
83% of plan sponsors feel a strong responsibility for employees' financial well-being NEW YORK, June 25, 2025 /PRNewswire/ -- J.P. Morgan Asset Management today released its sixth U.S. defined contribution (DC) plan sponsor survey findings, highlighting a growing commitment among plan sponsors to enhancing retirement outcomes and equipping participants with essential financial tools. This year's research, Scaling what works, shaping what's next, captures insights from 750 U.S. plan sponsors, providing a comprehensive snapshot of their perspectives and actions in refining retirement offerings. Plan sponsors are increasingly expanding financial wellness initiatives and developing innovative re
4 - JPMORGAN CHASE & CO (0000019617) (Issuer)
4 - JPMORGAN CHASE & CO (0000019617) (Issuer)
4 - JPMORGAN CHASE & CO (0000019617) (Issuer)
FWP - JPMORGAN CHASE & CO (0000019617) (Subject)
FWP - JPMORGAN CHASE & CO (0000019617) (Subject)
FWP - JPMORGAN CHASE & CO (0000019617) (Subject)
Robert W. Baird downgraded JPMorgan Chase from Neutral to Underperform and set a new price target of $235.00
TD Cowen initiated coverage of JPMorgan Chase with a rating of Buy and set a new price target of $305.00
Robert W. Baird upgraded JPMorgan Chase from Underperform to Neutral and set a new price target of $220.00 from $215.00 previously
SC 13D - JPMORGAN CHASE & CO (0000019617) (Filed by)
SC 13G/A - JPMORGAN CHASE & CO (0000019617) (Filed by)
SC 13G/A - JPMORGAN CHASE & CO (0000019617) (Subject)
NEW YORK, May 19, 2025 /PRNewswire/ -- J.P. Morgan Life Sciences Private Capital, the life sciences venture and growth equity arm within J.P. Morgan Asset Management, today announced the appointment of Dashyant (Dash) Dhanak, Ph.D., as Venture Partner. Dr. Dhanak will leverage his deep scientific and operational experience in therapeutics research and development to build and grow companies with Life Sciences Private Capital. Dr. Dhanak is a seasoned pharmaceutical research and development expert with over 30 years of experience. Most recently, Dr. Dhanak was the Chief Scienti
New role unifies asset manager's global real estate offering and expands access to firmwide capabilities NEW YORK, May 14, 2025 /PRNewswire/ -- J.P. Morgan Asset Management is enhancing its real estate business with the appointment of Chad Tredway as Global Head of Real Estate. In this new role, he will oversee real estate operations across the Americas, Europe, and Asia Pacific, increasing the firm's global reach and ability to deliver innovative investment opportunities. Mr. Tredway has a proven track record of managing real estate assets for retail and institutional client
PORTLAND, Ore., May 12, 2025 /PRNewswire/ -- Campbell Global, a leader in forestland investing and management, and a vital part of J.P. Morgan Asset Management's $400 billion alternatives business, is pleased to announce a significant leadership transition. Angie Davis, currently serving as President of Campbell Global, will succeed John Gilleland as Chief Executive Officer, effective October 1. Campbell Global, a pioneer in timberland investing, has been a full-service investment advisor focusing solely on commercial forestlands and related assets. Operating in core forest in
JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") has announced updated information relating to its third quarter dividend, common share repurchase program and regulatory capital requirements. Information can be found on the Firm's Investor Relations website at jpmorganchase.com/ir/news. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorganChase had $4.4 trillion in assets and $351 billion in stockholders' equity as of March 31, 2025. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction proc
As previously announced, JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") will host a conference call to review second-quarter 2025 financial results on Tuesday, July 15, 2025 at 8:30 a.m. (ET). The results are scheduled to be released at approximately 7:00 a.m. (ET). The live audio webcast and presentation slides will be available on www.jpmorganchase.com under Investor Relations, Events & Presentations. JPMorganChase will notify the public that financial results have been issued through its social media outlet @JPMorgan and @Chase on X, and by a press release over Business Wire that will provide the link to the Firm's Investor Relations website. In addition to being avail
JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") has declared dividends on the outstanding shares of the Firm's Series CC preferred stock. Information can be found on the Firm's Investor Relations website at https://www.jpmorganchase.com/ir/news. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorganChase had $4.4 trillion in assets and $351 billion in stockholders' equity as of March 31, 2025. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.